Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Preliminary results from study of MultiKine in head and neck cancer patients

Oct. 9, 1997

Genentech returns rights to IDEC-Y2B8 to IDEC

Oct. 6, 1997

IL-2 + IFN-alpha in phase II for renal cell carcinoma

Oct. 1, 1997

Techniclone submits IND for malignant glioma

Sep. 30, 1997

Ribi's melanoma vaccine accepted for fast-track review in Canada

Sep. 29, 1997

Betathine available for licensing from Dovetail

Sep. 29, 1997

Novopharm Biotech seeks approval for melanoma vaccine trial

Sep. 17, 1997

PDL grants antibody humanization patent license to NeoRx

Sep. 17, 1997

Biomira reports phase II results for cancer vaccine

Sep. 15, 1997

New clinical study on Multikine initiated in Canada

Sep. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.